214 related articles for article (PubMed ID: 10227615)
21. Evaluation of adjunctive perampanel in patients with refractory partial-onset seizures: results of randomized global phase III study 305.
French JA; Krauss GL; Steinhoff BJ; Squillacote D; Yang H; Kumar D; Laurenza A
Epilepsia; 2013 Jan; 54(1):117-25. PubMed ID: 22905857
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and safety of adjunctive topiramate in infants (1-24 months) with refractory partial-onset seizures: a randomized, multicenter, open-label phase 1 study.
Manitpisitkul P; Shalayda K; Todd M; Wang SS; Ness S; Ford L
Epilepsia; 2013 Jan; 54(1):156-64. PubMed ID: 23157581
[TBL] [Abstract][Full Text] [Related]
23. Clinical efficacy of topiramate as add-on therapy in refractory partial epilepsy: the European experience.
Ben-Menachem E
Epilepsia; 1997; 38 Suppl 1():S28-30. PubMed ID: 9092955
[TBL] [Abstract][Full Text] [Related]
24. Efficacy and safety of topiramate for the treatment of chronic migraine: a randomized, double-blind, placebo-controlled trial.
Silberstein SD; Lipton RB; Dodick DW; Freitag FG; Ramadan N; Mathew N; Brandes JL; Bigal M; Saper J; Ascher S; Jordan DM; Greenberg SJ; Hulihan J;
Headache; 2007 Feb; 47(2):170-80. PubMed ID: 17300356
[TBL] [Abstract][Full Text] [Related]
25. Once-daily USL255 as adjunctive treatment of partial-onset seizures: randomized phase III study.
Chung SS; Fakhoury TA; Hogan RE; Nagaraddi VN; Blatt I; Lawson B; Arnold S; Anders B; Clark AM; Laine D; Meadows RS; Halvorsen MB;
Epilepsia; 2014 Jul; 55(7):1077-87. PubMed ID: 24902983
[TBL] [Abstract][Full Text] [Related]
26. Adjunctive brivaracetam for uncontrolled focal and generalized epilepsies: results of a phase III, double-blind, randomized, placebo-controlled, flexible-dose trial.
Kwan P; Trinka E; Van Paesschen W; Rektor I; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):38-46. PubMed ID: 24116853
[TBL] [Abstract][Full Text] [Related]
27. Lamotrigine adjunctive therapy among children and adolescents with primary generalized tonic-clonic seizures.
Trevathan E; Kerls SP; Hammer AE; Vuong A; Messenheimer JA
Pediatrics; 2006 Aug; 118(2):e371-8. PubMed ID: 16847080
[TBL] [Abstract][Full Text] [Related]
28. Adjunctive therapy with oxcarbazepine in children with partial seizures. The Oxcarbazepine Pediatric Study Group.
Glauser TA; Nigro M; Sachdeo R; Pasteris LA; Weinstein S; Abou-Khalil B; Frank LM; Grinspan A; Guarino T; Bettis D; Kerrigan J; Geoffroy G; Mandelbaum D; Jacobs T; Mesenbrink P; Kramer L; D'Souza J
Neurology; 2000 Jun; 54(12):2237-44. PubMed ID: 10881246
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of once-daily extended-release topiramate (USL255): a subgroup analysis based on the level of treatment resistance.
Hogan RE; Blatt I; Lawson B; Nagaraddi V; Fakhoury TA; Anders B; Clark AM; Laine D; Halvorsen MB; Chung SS
Epilepsy Behav; 2014 Dec; 41():136-9. PubMed ID: 25461205
[TBL] [Abstract][Full Text] [Related]
30. Randomized, double-blind, placebo-controlled trial of ezogabine (retigabine) in partial epilepsy.
French JA; Abou-Khalil BW; Leroy RF; Yacubian EM; Shin P; Hall S; Mansbach H; Nohria V;
Neurology; 2011 May; 76(18):1555-63. PubMed ID: 21451152
[TBL] [Abstract][Full Text] [Related]
31. [Topiramate (Topamax). Pharmacological characteristics and current use in epilepsy treatment].
Bauer J; Schwalen S
Nervenarzt; 2000 Jun; 71(6):495-501. PubMed ID: 10919147
[TBL] [Abstract][Full Text] [Related]
32. Topiramate: a review of its use in childhood epilepsy.
Ormrod D; McClellan K
Paediatr Drugs; 2001; 3(4):293-319. PubMed ID: 11354701
[TBL] [Abstract][Full Text] [Related]
33. Topiramate as add-on therapy: pooled analysis of randomized controlled trials in adults.
Reife R; Pledger G; Wu SC
Epilepsia; 2000; 41(S1):66-71. PubMed ID: 10768304
[TBL] [Abstract][Full Text] [Related]
34. Topiramate reduces headache days in chronic migraine: a randomized, double-blind, placebo-controlled study.
Diener HC; Bussone G; Van Oene JC; Lahaye M; Schwalen S; Goadsby PJ;
Cephalalgia; 2007 Jul; 27(7):814-23. PubMed ID: 17441971
[TBL] [Abstract][Full Text] [Related]
35. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial.
Ryvlin P; Werhahn KJ; Blaszczyk B; Johnson ME; Lu S
Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083
[TBL] [Abstract][Full Text] [Related]
36. Topiramate: a new antiepileptic drug.
Privitera MD
Ann Pharmacother; 1997 Oct; 31(10):1164-73. PubMed ID: 9337443
[TBL] [Abstract][Full Text] [Related]
37. Pregabalin adjunctive therapy for focal onset seizures in children 1 month to <4 years of age: A double-blind, placebo-controlled, video-electroencephalographic trial.
Mann D; Antinew J; Knapp L; Almas M; Liu J; Scavone J; Yang R; Modequillo M; Makedonska I; Ortiz M; Kyrychenko A; Nordli D; Farkas V; Farkas MK;
Epilepsia; 2020 Apr; 61(4):617-626. PubMed ID: 32189338
[TBL] [Abstract][Full Text] [Related]
38. Topiramate in migraine prevention: a double-blind, placebo-controlled study.
Storey JR; Calder CS; Hart DE; Potter DL
Headache; 2001; 41(10):968-75. PubMed ID: 11903524
[TBL] [Abstract][Full Text] [Related]
39. Randomized dose-controlled study of topiramate as first-line therapy in epilepsy.
Arroyo S; Dodson WE; Privitera MD; Glauser TA; Naritoku DK; Dlugos DJ; Wang S; Schwabe SK; Twyman RE;
Acta Neurol Scand; 2005 Oct; 112(4):214-22. PubMed ID: 16146489
[TBL] [Abstract][Full Text] [Related]
40. Topiramate as adjunctive therapy in refractory partial epilepsy: pooled analysis of data from five double-blind, placebo-controlled trials.
Reife RA; Pledger GW
Epilepsia; 1997; 38 Suppl 1():S31-3. PubMed ID: 9092956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
